These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35287415)

  • 1. The Demographic Attributes, Clinical Features, and Optimal Management of 143 Patients with Pemphigus: A Retrospective Observational Study from a Tertiary Care Center of India.
    Mahajan VK; Mehta KS; Sharma J; Kumar P; Chauhan PS; Singh R; Manvi S; Vashist S; Sharma A; Sharma AL
    Indian Dermatol Online J; 2022; 13(2):207-215. PubMed ID: 35287415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non Comparative Study on Various Pulse Regimens (DCP, DAP and DMP) in Pemphigus: Our Experience.
    Hassan I; Sameem F; Masood QM; Majid I; Abdullah Z; Ahmad QM
    Indian J Dermatol; 2014 Jan; 59(1):30-4. PubMed ID: 24470657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
    Kanwar AJ; Kaur S; Thami GP
    Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris.
    Das S; Agarwal K; Singh S; Halder D; Sinha S; De A
    Indian J Dermatol; 2021; 66(2):223. PubMed ID: 34188295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
    Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
    Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study.
    Sharma VK; Bhari N; Gupta S; Sahni K; Khanna N; Ramam M; Sethuraman G
    Indian J Dermatol Venereol Leprol; 2016; 82(4):389-94. PubMed ID: 27279296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab: A Magic Bullet for Pemphigus.
    Anandan V; Jameela WA; Sowmiya R; Kumar MMS; Lavanya P
    J Clin Diagn Res; 2017 Apr; 11(4):WC01-WC06. PubMed ID: 28571245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.
    Porro AM; Hans Filho G; Santi CG
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):20-32. PubMed ID: 31166407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
    Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
    J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of a single-center clinical experience toward development of curative treatment of 123 pemphigus patients with a long-term follow-up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion-protecting drugs.
    Grando SA
    Int J Dermatol; 2019 Jan; 58(1):114-125. PubMed ID: 30047585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
    Khatri ML
    Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pemphigus: a review].
    Joly P; Sin C
    Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up.
    Ahmed AR; Nguyen T; Kaveri S; Spigelman ZS
    Int Immunopharmacol; 2016 May; 34():25-31. PubMed ID: 26919279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
    Sethy PK; Khandpur S; Sharma VK
    Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.